Protocol-based management strategy for post-endoscopic retrograde cholangiopancreatography pancreatitis: can it make a difference?
Bhasin
Deepak K
DK
Rana
Surinder S
SS
Nadkarni
Nikhil
N
D015746:Abdominal Pain / Q000209:etiology / Q000517:prevention & control; D000700:Analgesics / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D002985:Clinical Protocols; D004750:Enteral Nutrition; D005440:Fluid Therapy; D006801:Humans; D007902:Length of Stay; D008049:Lipase / Q000097:blood; D009294:Narcotics / Q000627:therapeutic use*; D010147:Pain Measurement; D010195:Pancreatitis / Q000150:complications / Q000000981:diagnostic imaging / Q000201:enzymology / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D010288:Parenteral Nutrition; D015397:Program Evaluation; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000700:Analgesics; D000900:Anti-Bacterial Agents; D009294:Narcotics; D008049:Lipase